State NV
Clinical Trials in Nevada
Nevada is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Nevada and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.
Right now ClinicalMetric tracks 91 actively recruiting studies with Nevada sites out of 91 registered in total. The busiest research areas in Nevada are Breast Cancer, Ovarian Neoplasms, Metastatic Breast Cancer. Leading sponsors running trials in the state include National Cancer Institute (NCI), AstraZeneca, Eli Lilly and Company. By stage, Nevada trials break down as Phase 1 (7), Phase 2 (26), Phase 3 (42), Phase 4 (2).
All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.
Top Conditions in Nevada
Frequently Asked Questions — Clinical Trials in Nevada
How many clinical trials are currently recruiting in Nevada?
ClinicalMetric currently tracks 91 actively recruiting clinical trials with at least one location in Nevada. The total number of registered studies—including active but not currently enrolling trials—is 91. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Nevada?
Nevada hosts clinical trials across a broad range of medical conditions, including Breast Cancer, Ovarian Neoplasms, Metastatic Breast Cancer, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Nevada serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Nevada?
To join a clinical trial in Nevada, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Nevada maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in Nevada
NCT05211895 Phase 3
Recruiting
A Global Study to Assess the Effects of Durvalumab + Domvanalimab Following Conc...
Condition
Non-Small Cell Lung Cancer
Enrollment
860 pts
Location
United States, Belgium, Brazil
Sponsor
AstraZeneca
NCT06679881 Phase 3
Recruiting
Long-Term, Open-label Study of Oral Deucrictibant Extended-Release Tablet for Pr...
Condition
Hereditary Angioedema (HAE)
Enrollment
170 pts
Location
United States, Argentina, Australia
Sponsor
Pharvaris Netherlands B.V.
NCT06312137 Phase 3
Recruiting
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzum...
Condition
Non Small Cell Lung Cancer
Enrollment
780 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
NCT06942949 N/A
Recruiting
Evaluation of Enhanced Lithotripsy System (ELS) in the Treatment of Urinary Ston...
Condition
Kidney Calculi; Ureteral Calculi
Enrollment
101 pts
Location
United States
Sponsor
Avvio Medical
NCT06566716 N/A
Recruiting
A Diagnostic Test to Evaluate Cancer Risk Before Surgery in Women with an Ovaria...
Condition
Ovarian Neoplasms
Enrollment
1,000 pts
Location
United States
Sponsor
Cleo Diagnostics Ltd
NCT06485843 Phase 2
Recruiting
An Study to Evaluate Safety and Tolerability of OA-SYS in Subjects With Moderate...
Condition
Osteoarthritis
Enrollment
400 pts
Location
United States
Sponsor
Ageless Biotech, Inc.
NCT07221877 Phase 4
Recruiting
A Study to Evaluate the Effect of KarXT on Urological Safety
Condition
Schizophrenia
Enrollment
60 pts
Location
United States
Sponsor
Bristol-Myers Squibb
NCT07428499 Phase 3
Recruiting
Phase 3 Extension Study of ADX-324 in Participants With Hereditary Angioedema (H...
Condition
Hereditary Angioedema (HAE)
Enrollment
90 pts
Location
United States, Argentina, Australia
Sponsor
ADARx Pharmaceuticals, Inc.
NCT07213804 Phase 3
Recruiting
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum...
Condition
Ovarian Neoplasms
Enrollment
1,630 pts
Location
United States, Australia, Austria
Sponsor
Eli Lilly and Company
NCT07662044 Phase 3
Recruiting
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone o...
Condition
Type 2 Diabetes Mellitus
Enrollment
800 pts
Location
United States, Argentina, China
Sponsor
AstraZeneca
NCT00196742 N/A
Recruiting
Fabry Disease Registry & Pregnancy Sub-registry
Condition
Fabry Disease
Enrollment
9,000 pts
Location
United States, Argentina, Australia
Sponsor
Genzyme, a Sanofi Company
NCT03876054 N/A
Recruiting
Long-Term Real-World Outcomes Study on Patients Implanted With a Neurostimulator
Condition
Chronic Pain
Enrollment
2,000 pts
Location
United States, Australia, Belgium
Sponsor
Abbott Medical Devices
NCT03424005 Phase 1, Phase 2
Recruiting
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in...
Condition
Metastatic Breast Cancer
Enrollment
1,132 pts
Location
United States, Australia, France
Sponsor
Hoffmann-La Roche
NCT07284667 Phase 2
Recruiting
ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant...
Condition
Major Depressive Disorder (MDD)
Enrollment
153 pts
Location
United States
Sponsor
ACADIA Pharmaceuticals Inc.
NCT04852887 Phase 3
Recruiting
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, O...
Condition
Stage I Breast Cancer
Enrollment
1,670 pts
Location
United States, Canada, Hong Kong
Sponsor
NRG Oncology
NCT04772131 N/A
Recruiting
Desara ® One Single Incision Sling 522 Study
Condition
Stress Urinary Incontinence
Enrollment
300 pts
Location
United States
Sponsor
Caldera Medical, Inc.
NCT07592273 Phase 2, Phase 3
Recruiting
Surabgene Lomparvovec Administered in the Suprachoroidal Space in Adult Particip...
Condition
Diabetic Retinopathy
Enrollment
576 pts
Location
United States, Puerto Rico
Sponsor
AbbVie
NCT07494305 Phase 2
Recruiting
Multicenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment o...
Condition
Bipolar I Disorder
Enrollment
320 pts
Location
United States
Sponsor
LB Pharmaceuticals Inc.
NCT02523014 Phase 2
Recruiting
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating ...
Condition
Intracranial Meningioma
Enrollment
124 pts
Location
United States
Sponsor
Alliance for Clinical Trials i
NCT06215716 Phase 3
Recruiting
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Stea...
Condition
NASH With Fibrosis
Enrollment
1,650 pts
Location
United States, Argentina, Australia
Sponsor
Akero Therapeutics, Inc
NCT00358943 N/A
Recruiting
International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Preg...
Condition
Gaucher Disease
Enrollment
12,000 pts
Location
United States, Argentina, Australia
Sponsor
Genzyme, a Sanofi Company
NCT05918861 Phase 3
Recruiting
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Rece...
Condition
Acute Coronary Syndrome
Enrollment
2,000 pts
Location
United States, Canada, Puerto Rico
Sponsor
DalCor Pharmaceuticals
NCT06316297 Phase 1, Phase 2
Recruiting
Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Ad...
Condition
Acne
Enrollment
800 pts
Location
United States, Australia, Canada
Sponsor
Sanofi Pasteur, a Sanofi Compa
NCT04402788 Phase 2, Phase 3
Recruiting
Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment ...
Condition
Extensive Stage Lung Small Cell Carcinoma
Enrollment
138 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT07676110 N/A
Recruiting
The Impact of Enhanced Music & Natural Visuals on Emotional Health
Condition
Emotion Management Skills
Enrollment
200 pts
Location
United States
Sponsor
soundBrilliance LLC
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology